1. Marmor MF, Arden GB, Nisson SE, et al. Standard for clinical electroretinography. Arch Ophthalmol. 1989. 107:816–819.
2. Marmor MF, Zrenner E. Standard for clinical electroretinography. Doc Ophthalmol. 1995. 89:199–210.
3. Marmor MF. An updated standard for clinical electroretinography. Arch Ophthalmol. 1995. 113:1375–1376.
4. Marmor MF. The ERG is alive and well. Arch Ophthalmol. 1995. 113:1371–1372.
5. Drasdo N, Aldedasi YH, Chiti Z, et al. The s-cone PHNR and pattern ERG in primary open angle glaucoma. Invest Ophthalmol Vis Sci. 2001. 42:1266–1272.
6. Viswanathan S, Frishman LJ, Robson JG, Walters JW. The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Invest Ophthalmol Vis Sci. 2001. 42:514–522.
7. Colotto A, Falsini B, Salgarello T, et al. Photopic negative response of the human ERG: losses associated with glaucomatous damage. Invest Ophthalmol Vis Sci. 2000. 41:2205–2211.
8. Machida S, Gotoh Y, Tanaka M, et al. Predominant loss of the photopic negative response in central retinal artery occlusion. Am J Ophthalmol. 2004. 137:938–940.
9. Korean Society for Clinical Electrophysiology of Vision (KSCEV). Korean Society for Clinical Electrophysiology of Vision. Clinical electrophysiology of vision. 2009. Seoul: Korean Society for Clinical Electrophysiology of Vision;36–45.
10. Viswanathan S, Frishman LJ, Robson JG, et al. The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma. Invest Ophthalmol Vis Sci. 1999. 40:1124–1136.
11. Ventura LM, Sorokac N, De Los Santos R, et al. The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest Ophthalmol Vis Sci. 2006. 47:3904–3911.
12. Barkana Y, Harizman N, Gerber Y, et al. Measurements of optic disk size with HRT II, Stratus OCT, and funduscopy are not interchangeable. Am J Ophthalmol. 2006. 142:375–380.
13. Jonas JB, Budde WM, Panda-Jonas S. Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol. 1999. 43:293–320.
14. Ambati J, Chalam KV, Chawla DK, et al. Elevated gamma aminobutyric acid, glutamate and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997. 115:1161–1166.
15. Nakazawa T, Takahashi H, Nishijima K, et al. Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J Neurochem. 2007. 100:1018–1031.
16. Kizawa J, Machida S, Kobayashi T, et al. Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol. 2006. 50:367–373.